Paraneoplastic pemphigus: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 40: | Line 40: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Revision as of 17:37, 18 March 2025
Paraneoplastic Pemphigus is a rare, multiorgan autoimmune disease that is associated with malignancies. It is characterized by painful mucosal erosions and polymorphous skin lesions. The disease is often associated with lymphoproliferative disorders such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and Castleman's disease.
Etiology
The exact cause of Paraneoplastic Pemphigus is unknown. However, it is believed to be an autoimmune disorder, which means the body's immune system mistakenly attacks healthy cells. In the case of Paraneoplastic Pemphigus, the immune system attacks the skin and mucous membranes.
Symptoms
The symptoms of Paraneoplastic Pemphigus can vary greatly from person to person. However, common symptoms include:
- Painful sores in the mouth and on the lips
- Skin rashes, often on the chest, back, and abdomen
- Blisters on the skin and mucous membranes
- Severe conjunctivitis
- Difficulty swallowing due to sores in the esophagus
Diagnosis
Diagnosis of Paraneoplastic Pemphigus often involves a combination of clinical findings, histopathology, immunofluorescence studies, and serology. A skin biopsy is often performed to confirm the diagnosis.
Treatment
Treatment of Paraneoplastic Pemphigus is primarily aimed at managing the symptoms and treating the underlying malignancy. This may involve the use of corticosteroids, immunosuppressive drugs, and other therapies.
Prognosis
The prognosis for individuals with Paraneoplastic Pemphigus is generally poor, with a high mortality rate. The prognosis is often dependent on the underlying malignancy and the individual's response to treatment.
